Mintz represented Sixth Street in connection with a $1.3 billion financing – alongside co-investor Blackstone Credit & Insurance – in support of the combination of Paratek Pharmaceuticals (Paratek) and Radius… Read More
Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE offers an innovative new option… Read More
VANCOUVER, BC, Canada — Integrated Nanotherapeutics (INT), a biotechnology company developing next-generation lipid nanoparticle (LNP) therapeutics for immune-mediated diseases, today announced that it has been awarded funding through the Genome… Read More
VANCOUVER, BC – Eight research teams in British Columbia will receive a combined $8 million in federal funding towards academia-industry collaborations on research solutions that are implementation and market ready…. Read More
Vancouver, B.C. – Acuitas Therapeutics, the global leader in lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, recently announced that the company’s partner, AstraZeneca, has published a new study… Read More
